MicroRNA-21 as a Regulator of Cancer Stem Cell Properties in Oral Cancer
Cells · 10.01.2025 · 14 (2) · 91
DOI: 10.3390/cells14020091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 10.01.2025. Verfasst von Milica Jaksic Karisik und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, School of Dental Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia. Hauptthemen laut MEDLINE: MicroRNAs, Neoplastic Stem Cells, Mouth Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Fund of the Republic of Serbia.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) is a highly aggressive malignancy with poor prognosis, mainly due to the presence of cancer stem cells (CSCs), a small subpopulation of cells that contribute to therapy resistance and tumor progression. The principal objective of this study was to investigate the role of miRNA-21 in the maintenance of cancer cell stemness and the possibility of altering it. The CD44 antigen was used as a marker for CSC isolation from oral cancer cell cultures. CD44+ and CD44− populations were sorted via magnetic separation. miRNA-21 inhibition was performed in CD44+ cells via transfection. CD44+ cells possessed a significantly higher migration and invasion potential compared to CD44− cells, higher levels of miRNA-21 (p = 0.004) and β-catenin (p = 0.005), and lower levels of BAX (p = 0.015). miRNA-21 inhibition in CD44+ cells reduced migration, invasion, and colony formation while increasing apoptosis. Stemness markers were significantly downregulated following miRNA-21 inhibition: OCT4 (p = 0.013), SOX2 (p = 0.008), and NANOG (p = 0.0001), as well as β-catenin gene (CTNNB1) (p < 0.05), an important member of WNT signaling pathway. Apoptotic activity was enhanced, with a significant downregulation of the antiapoptotic Bcl-2 (p = 0.008) gene. In conclusion, miRNA-21 plays a critical role in the regulation of oral cancer CD44+ cells properties. Targeting and inhibiting miRNA-21 in CD44+ cells could represent a promising novel strategy in OSCC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Genetics, School of Dental Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia.
- Department of Neuroscience, Imaging and Clinical Sciences, University of Chieti-Pescara, 66100 Chieti, Italy.
- Clinic for Maxillofacial Surgery, School of Dental Medicine, University of Belgrade, Dr. Subotica 8, 11000 Belgrade, Serbia.
ORCID-Profile: Milica Jaksic Karisik, Milos Lazarevic, Dijana Mitic, Maja Milosevic Markovic, Nicole Riberti, Drago Jelovac, Jelena Milasin
Förderung
- Science Fund of the Republic of Serbia
Zitieren
APA
Jaksic Karisik, M., Lazarevic, M., Mitic, D., Milosevic Markovic, M., Riberti, N., Jelovac, D., & Milasin, J. (2025). MicroRNA-21 as a Regulator of Cancer Stem Cell Properties in Oral Cancer. Cells, 14(2), 91. https://doi.org/10.3390/cells14020091
Vancouver
Jaksic Karisik M, Lazarevic M, Mitic D, Milosevic Markovic M, Riberti N, Jelovac D, et al. MicroRNA-21 as a Regulator of Cancer Stem Cell Properties in Oral Cancer. Cells. 2025;14(2):91. doi:10.3390/cells14020091
BibTeX
@article{JaksicKarisik2025,
author = {Jaksic Karisik, Milica and Lazarevic, Milos and Mitic, Dijana and Milosevic Markovic, Maja and Riberti, Nicole and Jelovac, Drago and Milasin, Jelena},
title = {MicroRNA-21 as a Regulator of Cancer Stem Cell Properties in Oral Cancer},
journal = {Cells},
year = {2025},
volume = {14},
number = {2},
pages = {91},
doi = {10.3390/cells14020091}
}
EUVIMED